ReviewChemistry & biodiversity2026
Boswellic Acid Derivatives: A Traditional and Multifunctional Therapeutic Agent for Infectious and Non-Infectious Diseases - A Comprehensive Review.
Review in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural products and their intricate framework always offer an unexplored source of chemotypes for any drug discovery. It is identified that >70% of the drugs were discovered directly from the natural sources or their direct analogs. Boswellic acids (BA) are one of such structurally diverse bioactive components that are isolated from the resin of the Boswellia genus. This resin is used for multiple ailments in indigenous medicine, especially in Indian Ayurveda and the Chinese medicine system. However, its complex structure and low bioavailability limit its applications in therapeutic use. Modifying BA (an abundant molecule from nature) semi-synthetically can improve biological and pharmacokinetic properties tremendously. During the past 35 years (1990-2025), numerous semi-synthetic modifications of BA have been established. The synthesized derivatives of BA possess novel molecular mechanisms against infectious and non-infectious diseases, making them valuable candidates for drug development. Based on the chemical/ biological importance, the review is presented, which covers the molecular scaffolds and pharmacological activities of BAs for various infectious and non-infectious diseases. Further, the structure-activity relationship provides a valuable addition to the drug discovery program.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.